The Valley Desk

NCT06443944 · Expanded access

An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG

Overall registry status Available

Conditions Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Urologic Cancer, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov